Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations

por Kendall, Emily A., Malhotra, Shelly, Cook-Scalise, Sarah, Denkinger, Claudia M., Dowdy, David W.
Publicado 2019

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

por Gomez, Gabriela Beatriz, Siapka, Mariana, Conradie, Francesca, Ndjeka, Norbert, Garfin, Anna Marie Celina, Lomtadze, Nino, Avaliani, Zaza, Kiria, Nana, Malhotra, Shelly, Cook-Scalise, Sarah, Juneja, Sandeep, Everitt, Daniel, Spigelman, Melvin, Vassall, Anna
Publicado 2021

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

por Mulder, Christiaan, Rupert, Stephan, Setiawan, Ery, Mambetova, Elmira, Edo, Patience, Sugiharto, Jhon, Useni, Sani, Malhotra, Shelly, Cook-Scalise, Sarah, Pambudi, Imran, Kadyrov, Abdullaat, Lawanson, Adebola, van den Hof, Susan, Gebhard, Agnes, Juneja, Sandeep, Sohn, Hojoon
Publicado 2022

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

por van de Berg, S. E. J., Pelzer, P. T., van der Land, A. J., Abdrakhmanova, E., Ozi, A. Muhammad, Arias, M., Cook-Scalise, S., Dravniece, G., Gebhard, A., Juneja, S., Handayani, R., Kappel, D., Kimerling, M., Koppelaar, I., Malhotra, S., Myrzaliev, B., Nsa, B., Sugiharto, J., Engel, N., Mulder, C., van den Hof, S.
Publicado 2021